Company intelligence / Profile preview

RAW Pharma

Ownership: Private
Development stage: Commercial

Overview

RAW Pharma is an Egyptian startup pharmaceutical company aiming to become one of the leading providers of high-quality, cost-effective branded generic medicines in Egypt and the broader Middle East/Africa region. The company emphasizes unique product offerings, professional staff, and innovation in manufacturing processes. It seeks to address unmet medical needs by selecting recent molecules for its portfolio but does not appear to develop new chemical entities or biologic drugs at this time.

Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on RAW Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAW Pharma.

Explore the full profile